- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on May 19, 2026
B-DE-MF-000006543-30109SPEctoin® Allergy Nasal Spray 2% is an MDD-legacy medical device registered in EUDAMED. It is classified as Class I. Manufactured by bitop AG. Placed on the EU market in Germany. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
D-DE-MF-000006543-30109SP30109D-DE-MF-000006543-30109SP
DataMatrix generation currently supports GS1-issued UDIs. HIBCC / ICCBBA support is coming.
European Medical Device Nomenclature — the EU product classification assigned to this device.
Q0399ENT DEVICES - OTHER1 warning recorded — scroll inside the panel to see all entries.
CW999Primary placement in Germany; available across 1 country total.
| Country | On market since | Until |
|---|---|---|
| GermanyPrimary placement | Mar 19, 2010 | Dec 21, 2029 |
DE-MF-000006543Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
View in glossary →Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
View in glossary →Contains latex
A "contains latex" flag warns that a device contains natural rubber latex, which can trigger allergic reactions in sensitive patients.
View in glossary →CMR substance
A CMR flag warns that a device contains a substance that is carcinogenic, mutagenic or toxic to reproduction above a defined threshold.
View in glossary →Endocrine-disrupting substance
An endocrine-disruptor flag warns that a device contains a substance with endocrine-disrupting properties above a defined threshold.
View in glossary →Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
View in glossary →UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
View in glossary →MDR risk classes
MDR risk classes rank medical devices from lowest risk (Class I) to highest (Class III), which determines how much regulatory scrutiny they face.
View in glossary →Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →No certificate specifically references this device's Basic UDI-DI.
B-DE-MF-000006543-30058SXOn the marketEctoin® Allergy Eye Drops 2%B-DE-MF-000006543-30084SYOn the marketEctoin® Allergy Eye Drops 2%B-DE-MF-000006543-30085T2On the marketEctoin® Allergy Nasal Spray ForteB-DE-MF-000006543-30640TAOn the marketEctoin® Allergy Relief Eye DropsB-DE-MF-000006543-39960VWOn the marketEctoin® Allergy Relief Lozenges Honey LemonB-DE-MF-000006543-36001TCOn the marketCertificate health across this manufacturer's portfolio.
HZ 2678802-1ReissuedHZ 1342003-1SupplementedNotified body
A notified body is an independent organisation, designated by an EU country, that audits manufacturers and certifies higher-risk devices before they can be CE-marked.
View in glossary →Notified body
A notified body is an independent organisation, designated by an EU country, that audits manufacturers and certifies higher-risk devices before they can be CE-marked.
View in glossary →